Analysis of access to hypertensive and diabetic drugs in the Family Health Strategy, State of Pernambuco, Brazil

2015

Article référencé dans le Web of Science WOS:000235392000004

De Carvalho Barreto M.N.S., Pessoa Cesse E.A., Fonseca Lima R., Da Silva Marinho M.G., Da Silva Specht Y., Freese de Carvalho E.M., Fontbonne Annick

Revista Brasileira de Epidemiologia, 2015, 18 (2), p. 413-424 ISSN 1980-5497

OBJECTIVE: To evaluate the access to drugs for hypertension and diabetes and the direct cost of buying them among users of the Family Health Strategy (FHS) in the state of Pernambuco, Brazil. METHODS: Population-based, cross-sectional study of a systematic random sample of 785 patients with hypertension and 823 patients with diabetes mellitus who were registered in 208 randomly selected FHS teams in 35 municipalities of the state of Pernambuco. The selected municipalities were classified into three levels with probability proportional to municipality size (LS, large-sized; MS, medium-sized; SS, small-sized). To verify differences between the cities, we used the χ2 test. RESULTS: Pharmacological treatment was used by 91.2% patients with hypertension whereas 85.6% patients with diabetes mellitus used oral antidiabetic drugs (OADs), and 15.4% used insulin. The FHS team itself provided antihypertensive medications to 69.0% patients with hypertension, OADs to 75.0% patients with diabetes mellitus, and insulin treatment to 65.4%. The 36.9% patients with hypertension and 29.8% with diabetes mellitus that had to buy all or part of their medications reported median monthly cost of R 18.30, R 14.00, and R 27.61 for antihypertensive drugs, OADs, and insulin, respectively.

Santé : généralités [050] ; Nutrition, alimentation [054]

Fonds IRD [F B010065786]

fdi:010065786